UNLIMITED FREE ACCESS TO THE WORLD'S BEST IDEAS

close
Already an Engineering360 user? Log in.

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

Customize Your Engineering360 Experience

close
Privacy Policy

This is embarrasing...

An error occurred while processing the form. Please try again in a few minutes.

ASTM International - ASTM D5022-07

Standard Specification for Identification of Vials and Ampoules Containing Concentrated Solutions of Drugs to be Diluted Before Use (Withdrawn 2014)

inactive
Buy Now
Organization: ASTM International
Publication Date: 1 October 2007
Status: inactive
Page Count: 2
ICS Code (Medicaments): 11.120.10
scope:

1.1 This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration, as follows:

1.1.1 Container shape,

1.1.2 Labeling statements.

1.1.3 Vial closures and Flip-Off, type caps, and

1.1.4 Ampoule marking.

abstract:

This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration such as container shape, labeling statements, vial closures... View More

Document History

ASTM D5022-07
October 1, 2007
Standard Specification for Identification of Vials and Ampoules Containing Concentrated Solutions of Drugs to be Diluted Before Use (Withdrawn 2014)
This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration such as container shape, labeling statements, vial closures...
September 15, 1995
Standard Specification for Identification of Vials and Ampoules Containing Concentrated Solutions of Drugs to be Diluted Before Use
1.1 This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration, as follows: 1.1.1 Container shape, 1.1.2 Labeling...
September 15, 1995
Standard Specification for Identification of Vials and Ampoules Containing Concentrated Solutions of Drugs to be Diluted Before Use
1.1 This specification deals with identification of small volume containers of drugs intended to be diluted before parenteral administration, as follows: 1.1.1 Container shape, 1.1.2 Labeling...
Advertisement